Bionova Capital is a venture capital firm established in 2015 and headquartered in Lisboa, Portugal. The firm specializes in investing in early-stage and growth-stage companies within the healthcare, biotechnology, therapeutics, medical technology, and digital health sectors. Bionova Capital focuses primarily on European startups, aiming to support innovative solutions in life sciences. The firm typically invests between €200,000 and €1,000,000 per project, often taking minority stakes in the companies it supports. Founded by shareholders of Hovione, a leading pharmaceutical company, Bionova Capital leverages its industry expertise to identify and nurture groundbreaking ventures in the healthcare landscape.
Delox, founded in 2018 and based in Cascais, Portugal, specializes in the design and development of bio-decontamination devices aimed at creating clean and safe environments. As a spin-off from the Faculty of Sciences of the University of Lisbon, the company has developed innovative technologies, including DeloxHP, a solid formulation that safely releases concentrated hydrogen peroxide vapor. This advancement allows for the creation of compact and cost-effective bio-decontamination solutions, such as the Delox Box. Delox's applications span various sectors, including the sterilization of medical devices, bio-decontamination of laboratory equipment, and room decontamination in hospitals, the food industry, and even space environments. The company focuses on providing non-toxic solutions to combat microorganisms, ensuring safe handling and transportation of hydrogen peroxide through its cartridge system.
SolasCure
Series A in 2021
SolasCure Limited is a biotechnology company based in Wales, United Kingdom, focused on developing innovative solutions for patients with chronic wounds. Founded in 2017, the company is advancing its product Aurase, a hydrogel designed to facilitate wound debridement by removing dead, damaged, or infected tissue to enhance healing. Aurase incorporates a recombinant enzyme derived from maggots, leveraging biomimicry and evidence-based medicine to improve wound care outcomes. SolasCure aims to provide effective wound bed preparation across various healthcare settings, ultimately accelerating the healing process for individuals suffering from chronic wounds.
AdaptTech
Venture Round in 2021
AdaptTech is a biomedical company based in Birmingham, United Kingdom, that specializes in developing innovative wearable technologies aimed at enhancing the quality of life for individuals with physical disabilities. Founded in 2015, the company offers a range of products designed to assist clinicians in achieving better socket fitting and monitoring for patients who have lost a lower limb. Key offerings include the INSIGHT Scanner, which quickly creates a three-dimensional model of prosthetic sockets, the INSIGHT Wearable that collects real-time biometric data, and the INSIGHT App that provides users with easy access to their results. Through these advancements, AdaptTech seeks to improve the overall experience and outcomes for those relying on lower limb prosthetics.
Vaxdyn
Seed Round in 2021
Vaxdyn specializes in the development of vaccines and immunotherapies aimed at preventing infectious diseases, particularly those caused by antibiotic-resistant pathogens. The company employs innovative technologies, including antigens, immunomodulators, nanoparticles, and monoclonal antibodies, to create effective vaccines that help mitigate the impact of these drug-resistant infections on public health. Vaxdyn addresses customer inquiries through various channels, including phone, email, and online applications, ensuring accessible communication regarding their offerings.
SolasCure
Seed Round in 2018
SolasCure Limited is a biotechnology company based in Wales, United Kingdom, focused on developing innovative solutions for patients with chronic wounds. Founded in 2017, the company is advancing its product Aurase, a hydrogel designed to facilitate wound debridement by removing dead, damaged, or infected tissue to enhance healing. Aurase incorporates a recombinant enzyme derived from maggots, leveraging biomimicry and evidence-based medicine to improve wound care outcomes. SolasCure aims to provide effective wound bed preparation across various healthcare settings, ultimately accelerating the healing process for individuals suffering from chronic wounds.
Delox
Seed Round in 2018
Delox, founded in 2018 and based in Cascais, Portugal, specializes in the design and development of bio-decontamination devices aimed at creating clean and safe environments. As a spin-off from the Faculty of Sciences of the University of Lisbon, the company has developed innovative technologies, including DeloxHP, a solid formulation that safely releases concentrated hydrogen peroxide vapor. This advancement allows for the creation of compact and cost-effective bio-decontamination solutions, such as the Delox Box. Delox's applications span various sectors, including the sterilization of medical devices, bio-decontamination of laboratory equipment, and room decontamination in hospitals, the food industry, and even space environments. The company focuses on providing non-toxic solutions to combat microorganisms, ensuring safe handling and transportation of hydrogen peroxide through its cartridge system.
AdaptTech
Seed Round in 2016
AdaptTech is a biomedical company based in Birmingham, United Kingdom, that specializes in developing innovative wearable technologies aimed at enhancing the quality of life for individuals with physical disabilities. Founded in 2015, the company offers a range of products designed to assist clinicians in achieving better socket fitting and monitoring for patients who have lost a lower limb. Key offerings include the INSIGHT Scanner, which quickly creates a three-dimensional model of prosthetic sockets, the INSIGHT Wearable that collects real-time biometric data, and the INSIGHT App that provides users with easy access to their results. Through these advancements, AdaptTech seeks to improve the overall experience and outcomes for those relying on lower limb prosthetics.
Performetric
Seed Round in 2015
Performetric is a real-time monitoring system that allows the management of mental fatigue in a non-invasive way that aims to develop leisure and work context-aware environments that may improve the quality of life, wellness, mental health and individual performance. Moreover, it also aims to support a better management of the employees and their work time. This translates into a positive impact in the organization’s productivity and an increased quality of life and better health of the employees.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.